|
Propoxyphene Compound-65Drug - Propoxyphene Compound-65 The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Aspirin; Caffeine; Propoxyphene Hydrochloride
Strength -
389MG;32.4MG;65MG
Applicant -
SANDOZ
New Drug Application (NDA) Number -
083101
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 24, 1985
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Sandoz Inc
Propoxyphene Compound-65
Darvon Compound 389mg;32.4mg;32mg Capsule; Oral
Darvon Compound-65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound-65 389mg;32.4mg;65mg Capsule; Oral Orphenadrine Citrate, Aspirin, And Caffeine 770mg;60mg;50mg Tablet; Oral Orphengesic 385mg;30mg;25mg Tablet; Oral Orphengesic Forte 770mg;60mg;50mg Tablet; Oral Compound 65 389mg;32.4mg;65mg Capsule; Oral NewDrugInformation |